Retatrutide In Phase 2 trials, Retatrutide produced: Up to 24.2% weight loss after 48 weeks at higher doses Strong dose dependent responses across study groups A proportion of participants lost 15% or more of their body weight, particularly at the upper dose ranges
Peptide Therapy Peptide treatments offer targeted metabolic support for fat loss, energy, muscle tone, and appetite regulation
About the National Diabetes Prevention Program | CDC
Can I take B12 injections every week
Sign In Trouble signing in
[10] In the SURMOUNT-1 trial, patients with obesity achieved average weight reductions of approximately 15-21% of body weight over 72 weeks, alongside improvements in cardiovascular risk factors including blood pressure and lipid profiles, though cardiovascular outcome benefits have not yet been established